Navigation Links
BMP Sunstone Receives SFDA Acceptance for Enablex(R) Clinical Trial
Date:5/6/2008

A Milestone Reached to Commercialize Leading OAB Drug in China

PLYMOUTH MEETING, Pa., May 6 /Xinhua-PRNewswire-FirstCall/ -- BMP Sunstone Corporation (Nasdaq: BJGP) ("BMP Sunstone" or the "Company") today announced that its Clinical Trial Application ("CTA") for Enablex(R) (Darifenacin) was officially accepted by China's State Food & Drug Administration ("SFDA"). CTA acceptance is a key SFDA requirement prior to pursuing a clinical trial and, ultimately, completing commercialization of a pharmaceutical product in China. The Company hopes to begin the clinical trial in the first half of 2009, and estimates that receipt of a market license could occur sometime in 2011.

Enablex(R) is a prescription medicine used in adults to treat symptoms of urinary incontinence, urgency and frequency related to an Overactive Bladder ("OAB"). Global annual sales of OAB medication are estimated to be USD$2.25 billion. In China, OAB afflicts an estimated 24-29% of the population over the age of 24, or over 200 million people. However, the treatment rates are historically low, with less than 15% of OAB sufferers in China seeking treatment.

"Today's announcement speaks to our unique ability to commercialize leading pharmaceutical products in the Chinese market," stated David Gao, Chief Executive Officer of BMP Sunstone. "CTA acceptance is one key step toward reaching marketability and we remain excited about the growth prospects for Enablex(R) in China. The addressable market for OAB medicines in China is a huge potentially opportunity and we believe we have the necessary resources to meet this developing market demand with Enablex(R)."

In November 2007, BMP Sunstone signed an exclusive agreement to register, market and distribute
'/>"/>

SOURCE BMP Sunstone Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
3. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
4. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
5. IsoTis Receives FDA Clearance for Accell Family of Products
6. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
7. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
8. IDM Pharma Receives Not Approvable Letter for Mifamurtide (L-MTP-PE) for the Treatment of Osteosarcoma
9. XTL Receives Staff Letter From NASDAQ
10. XTL Receives Staff Letter From NASDAQ; XTL may Transfer its ADR Listing to the NASDAQ Capital Market
11. Hemo-Stream(TM) Chronic Dialysis Catheter Receives FDA Clearance
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 24, 2014  United Therapeutics Corporation (NASDAQ: ... (NYSE: MDT ) has submitted a ... Drug Administration (FDA) for the use of Medtronic,s ... (including a newly developed catheter) for use with ... intravenously to patients with pulmonary arterial hypertension.   ...
(Date:12/24/2014)... GMO corn cases filed across the ... in the process of being consolidated in a Kansas ... In Re: Syngenta AG MIR 162 Corn Litigation, MDL ... District of Kansas. , Management of the Syngenta GMO ... U.S. District Judge John W. Lungstrum.* , As a ...
(Date:12/24/2014)... 23, 2014 The report ... as its definition, classification, application and industry ... manufacturing process, and product cost structure. Production ... The analysis also covers upstream raw materials, ... development trend and proposals. In the end, ...
(Date:12/24/2014)... 2014 Vermillion, Inc. (Nasdaq:   VRML), ... announced today that investors including Oracle Investment Management, ... and several Vermillion directors have agreed to purchase ... common stock and warrants to purchase unregistered shares ... Under the terms of the ...
Breaking Biology Technology:United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Carey Danis & Lowe Reports on Syngenta GMO Corn Transfer Order 2Worldwide Methyl Mercaptan Market 2015-2020 Forecasts on Development & Trends Now Available at ReportsnReports.com 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 2Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 3Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 4Vermillion Announces Equity Financing of up to $18.9 Million; Suspends ATM Program 5
... To further promote young researchers in Germany, the ... 14 new Research Training Groups. This has just ... the DFG in Bonn. The new Research Training ... their doctorates in a structured research and qualification ...
... www.replikins.com ) last week analyzed the most recent ... the infectivity of the H1N1 virus will increase ... for the immediate future. The company,s quantitative analysis ... PubMed, a standard scientific repository for published papers, ...
... Incorporated (Nasdaq: SPEX ), an innovator ... of technical and regulatory consulting services to food, ... it has fully regained compliance with all requirements ... as described below. Independent Director Requirement On May ...
Cached Biology Technology:DFG establishes 14 new research training groups 2DFG establishes 14 new research training groups 3DFG establishes 14 new research training groups 4DFG establishes 14 new research training groups 5DFG establishes 14 new research training groups 6DFG establishes 14 new research training groups 7Swine Flu (H1N1) Infectivity to Increase Markedly and Lethality to Remain Low According to Latest Replikin* Peptide Genomic Data 2Swine Flu (H1N1) Infectivity to Increase Markedly and Lethality to Remain Low According to Latest Replikin* Peptide Genomic Data 3Spherix Regains Full NASDAQ Compliance 2Spherix Regains Full NASDAQ Compliance 3
(Date:12/19/2014)... Calif. , Dec. 18, 2014  23andMe, Inc., ... of a study that pinpoints fine-scale differences in genetic ... States . Since immigrants first arrived ... United States has served as a meeting ... how American history and the ongoing mixing of peoples ...
(Date:12/17/2014)... 2014 The Defense Logistics Agency is ... detect and prevent counterfeit microcircuits from entering into ... started performing an in-house microcircuit anti-counterfeit initiative dubbed ... of purchased microcircuits while increasing their reliability throughout ... will be conducted at DLA,s Electronics Product Test ...
(Date:12/17/2014)... , Dec. 16, 2014 Research and Markets ... addition of the "Global Chemical Sensor Market ... http://photos.prnewswire.com/prnh/20130307/600769 One ... increasing demand for medical sensors in biomedical applications. ... for quick and correct diagnosis during surgical procedures. ...
Breaking Biology News(10 mins):23andMe Study Sketches Genetic Portrait of the United States 223andMe Study Sketches Genetic Portrait of the United States 323andMe Study Sketches Genetic Portrait of the United States 4Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Global Chemical Sensor Market 2015-2019: Key Vendors are Abbott Laboratories, Bayer, Hoffmann La-Roche, Johnson & Johnson, NGK Spark Plugs and Robert Bosch 2
... a preventive measure to patients in intensive care units ... from a study involving nearly sixthousand Dutch patients in ... have published their findings in an article in The ... During the study, a team of researchers compared the ...
... genetic signature associated with Alzheimer,s disease, the leading ... elderly. The research, published by Cell Press in ... of Human Genetics , uses a powerful, high-resolution ... devastating neurodegenerative disorder. Previous research linked ...
... An extract from grape seeds forces laboratory leukemia cells ... University of Kentucky. They found that within 24 hours, ... exposed to the extract. The investigators, who report ... Clinical Cancer Research , a journal of the ...
Cached Biology News:Fewer deaths with preventive antibiotic use 2Scientists make strides toward defining genetic signature of Alzheimer's disease 2Grape-seed extract kills laboratory leukemia cells, proving value of natural compounds 2
Recombinant Mouse IL-23, CF...
... ActivePro In Vitro Translation ... E.coli lysate, synthesizes higher ... well as proteins with ... competing kits. This results ...
... , Customer Peptide Synthesis , Containing one Phospho-Amino ... mg will be returned to customer conjugation of peptide to KLH ... Maintenance 102 days/each , Pre-immune bleed ... , Test bleed (app. 5 ml) x1 ...
Donor Goat Serum...
Biology Products: